https://www.selleckchem.com/Androgen-Receptor.html
Relapse was common (42%) in those who ceased medical therapy. After a median follow up of 3.9years there was one hepatocellular carcinoma and no cholangiocarcinomas. Our study confirms the preponderance of IgG4-SC in males and highlights the steroid response nature of this condition although relapse is common after steroid cessation. Progression to malignancy was uncommon. Our study confirms the preponderance of IgG4-SC in males and highlights the steroid response nature of this condition although relapse is common after steroid cessat